Cite
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020.
MLA
Basavaraju, Sridhar V., et al. “Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020.” Clinical Infectious Diseases, vol. 72, no. 12, June 2021, pp. e1004–09. EBSCOhost, https://doi.org/10.1093/cid/ciaa1785.
APA
Basavaraju, S. V., Patton, M. E., Grimm, K., Rasheed, M. A. U., Lester, S., Mills, L., Stumpf, M., Freeman, B., Tamin, A., Harcourt, J., Schiffer, J., Semenova, V., Li, H., Alston, B., Ategbole, M., Bolcen, S., Boulay, D., Browning, P., Cronin, L., & David, E. (2021). Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020. Clinical Infectious Diseases, 72(12), e1004–e1009. https://doi.org/10.1093/cid/ciaa1785
Chicago
Basavaraju, Sridhar V, Monica E Patton, Kacie Grimm, Mohammed Ata Ur Rasheed, Sandra Lester, Lisa Mills, Megan Stumpf, et al. 2021. “Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020.” Clinical Infectious Diseases 72 (12): e1004–9. doi:10.1093/cid/ciaa1785.